Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Featured

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according to trialists.

By Michael O'Riordan

February 24, 2026

Features

In-depth long reads from the TCTMD news team

See All

Year in Review: Women’s Heart Health in the Spotlight

By Caitlin E. Cox

December 23, 2025
Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

By Todd Neale

October 22, 2025
Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

By Michael O'Riordan

October 17, 2025
‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

By Michael O'Riordan

September 17, 2025
Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

By Todd Neale

May 19, 2025
What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

By Yael L. Maxwell

March 27, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.